Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aripiprazole-induced tardive dystonia.

Literature DB >> 17245464

Aripiprazole-induced tardive dystonia.

Elsie Oommen, Prabhat K Chand, P S V N Sharma.

Abstract

Entities: Chemical Disease

Year: 2006 PMID： 17245464 PMCID： PMC1764509 DOI： 10.4088/pcc.v08n0611c

Source DB: PubMed Journal: Prim Care Companion J Clin Psychiatry ISSN： 1523-5998

× No keyword cloud information.

6 in total

1. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.

Authors: S M Stahl
Journal: J Clin Psychiatry Date: 2001-12 Impact factor: 4.384

2. Aripiprazole-induced improvement in tardive dyskinesia.

Authors: Harpreet S Duggal
Journal: Can J Psychiatry Date: 2003-12 Impact factor: 4.356

Review 3. The current status of tardive dystonia.

Authors: Y A Aderibigbe; V C Jampala; T Mathews
Journal: Biol Psychiatry Date: 1999-03-15 Impact factor: 13.382

4. Lithium - induced tardive dystonia.

Authors: S Chakrabarti; P K Chand
Journal: Neurol India Date: 2002-12 Impact factor: 2.117

5. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.

Authors: Steven G Potkin; Anutosh R Saha; Mary J Kujawa; William H Carson; Mirza Ali; Elyse Stock; Joseph Stringfellow; Gary Ingenito; Stephen R Marder
Journal: Arch Gen Psychiatry Date: 2003-07

6. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

Authors: John M Kane; William H Carson; Anutosh R Saha; Robert D McQuade; Gary G Ingenito; Dan L Zimbroff; Mirza W Ali
Journal: J Clin Psychiatry Date: 2002-09 Impact factor: 4.384

6 in total

1. Exercise tolerance and quality of life in patients with known or suspected coronary artery disease.

Authors: Vasiliki Katsi; Georgios Georgiopoulos; Panagiota Mitropoulou; Konstantinos Kontoangelos; Zoi Kollia; Chara Tzavara; Dimitrios Soulis; Konstantinos Toutouzas; Dimitrios Oikonomou; Alberto Aimo; Konstantinos Tsioufis
Journal: Qual Life Res Date: 2021-04-24 Impact factor: 4.147

2. Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth.

Authors: Tamara Pringsheim; Asif Doja; Stacey Belanger; Scott Patten
Journal: Paediatr Child Health Date: 2011-11 Impact factor: 2.253

Aripiprazole-induced tardive dystonia.

1. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.

2. Aripiprazole-induced improvement in tardive dyskinesia.

Review 3. The current status of tardive dystonia.

4. Lithium - induced tardive dystonia.

5. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.

6. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1. Exercise tolerance and quality of life in patients with known or suspected coronary artery disease.

2. Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth.

3. [Not Available].

4. Role of aripiprazole in treatment-resistant schizophrenia.

5. Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.

6. Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.